The Corporate Roundtable registration is closed, if you would like to submit your name and interest for consideration, please contact email@example.com
AMIA Corporate Roundtables are fully catered events hosted by organizations looking to engage directly with leaders in the field. Participation in Corporate Roundtables is voluntary and based on your interest in the topic and availability. These events allow you to provide feedback on corporate strategies, inform product development, and learn what important biomedical and health informatics issues these companies are exploring.
Roundtables are by invitation only and are not eligible for CME/CE. Please select your top choices below, making sure your selections do no conflict with one another. You may select to join three roundtables from the registration list below. Click on the dates to learn more about the roundtables available at those times.
If accepted, you will receive an email confirmation from Kathryn Hitchcock, Director of Industry Partnerships, the week before Annual Symposium. A ticket for your selected roundtable(s) will print with your badge at registration.
At-a-Glance AMIA 2018 Corporate Roundtable
Making Medicines More Affordable for Patients: Delivering Drug Price and Benefit Information to Point of Care
Presenters: Michelle Mello, PhD, JD, Professor of Health Research and Policy, Professor of Law, Stanford University; Member of National Academy of Medicine, which issued 2017 Consensus Study Report, “Making Medicines Affordable, A National Imperative.”
Making medicines more affordable has become a top priority for patients and providers across the country. State and federal policymakers are responding to public pressure with a range of regulatory and legislative proposals aimed at reducing drug costs to patients and payers. Just this year, 24 states have enacted 37 laws that address drug price transparency. At the federal level, regulators have encouraged efforts to make drug price and benefit information available to patients and providers at the point of care. At this session we will hear from a policy expert about the challenges of making drugs more affordable. We will also engage participants in an interactive discussion about their thoughts on how technology solutions can be most effective at delivering patient-specific price and therapeutic alternative information at the point of care.
Target Audience: CIOs, CMIOs, CQOs, Prescribers, Pharmacists, and anyone interested in price transparency
The power of FHIR in the development of clinical intelligence
Presenters: Cole Erdmann, Cerner, director, clinical intelligence
During this roundtable, we will discuss how Fast Healthcare Interoperability Resources (FHIR) can be leveraged to develop clinical intelligence. We will show a new data science ecosystem that uses FHIR capabilities to capture discrete data elements with industry-accepted languages and standards. Health system researchers and decision-makers will benefit by assisting in the creation, processing and implementation of algorithms solving key clinical or operational challenges. We look forward to hearing feedback through a thoughtful discussion on the value and limitations of the approach as well as any potential barriers to adoption.
Target Audience: Researchers, c-suite/management, data scientists
Creating Time and Quality of Care
Presenters: Aaron Brauser (VP, Solutions Management, M*MODAL) and Gilan Eisaadawi, MD, PhD (CMIO), M*MODAL
By leveraging the AI and natural language understanding powered Computer-Assisted Physician Documentation (CAPD) functionality of our front-end speech recognition solutions, we deliver in-workflow feedback to the clinician while the note is being created, before it is even saved in the EHR.
The CAPD technology delivers real-time, automated feedback while the physician is dictating or typing, so that the patient record is complete and accurate right from the start and when appropriate acts as a medical advisor. This system effectively engages clinicians in a non-disruptive manner within their natural documentation workflow, ensuring physician satisfaction.
Target Audience: CMIOs, CMO, CIO, Population health, clinical informatics, care management and quality groups, oncology departments
Patient-Centered Medication Management: Taking the Next Step
Presenters: Anna Dover, PharmD, BCPS, Product Manager & John Doulis, Sr. Vice President, Clinical Solutions
Patient-centered medication management is a critical component toward the goal of achieving personalized medicine. We are in the early stages of this journey. Helping clinicians make safe and effective medication choices for their patients is the primary purpose of medication decision support systems. Analysis of clinical workflows and decision support provides many examples of over-alerting, under-alerting, insufficient information for decision making, and often presented at the wrong time. Clinicians are thus likely to ignore potentially important alerts.
In this roundtable discussion, we will discuss how leveraging additional patient inputs – such as lab results, genomic markers, and clinical scoring/surveillance systems – enables the presentation of meaningful and targeted patient-centered medication management at the most appropriate place in the EHR clinical workflow. We will discuss our current progress in this area and our planned CDS direction that is patient and population-informed for more precision and personalized decision support.
We would like to hear your insights on relevant clinical scenarios and how to integrate more robust analytics.
Target Audience: CMIOs, decision support subject matter experts, clinical informaticists, those responsible for deploying and optimizing CDS and medication workflows, Physicians, Pharmacists, and other clinicians
Getting the Most Out of Your Clinical Data
Presenters: Andrew S. Kanter, MD, MPH, FACMI, Chief Medical Officer, IMO, Steven Rube, MD, FAAFP, Medical Director of Clinical Services and Integration, IMO and Matthew Cardwell, PhD, VP Product Launch and Integration, IMO
Healthcare institutions have a growing need for aggregation of clinical data both within and outside of the EHR. As healthcare institutions examine the ever-increasing amount of clinical data, they face the significant challenge of utilizing this data in a meaningful way across the organization.
During this round table discussion, we will provide an overview of the current landscape of the use of these data elements, data normalization, as well as how "Groupers" play a significant strategic role within healthcare organizations. These areas include population health management, cohort identification, research efforts, meaningful use, and revenue cycle optimization. We will explore in this roundtable session where opportunities exist for improvement within these "Grouper" powered workflows, both in terms of authoring as well as use.
We will review and demo the system addressing different suite of scenarios:
- Clinical Documentation Improvement (CDI)
- Inpatient DRG/ICD10 management including CAC
- Outpatient HCC and Risk Payment management
- Quality Measures
- Ejection Fraction extraction from echo documents
- Homelessness status
- Clinical Decision Support
- Incidental Findings
- AAA – Finding follow ups in narrative that did not make into care plans
- Nodules – Tracking Lung nodules by size and ensuring follow up
- Pressure Ulcer monitoring at the point of care
- Critical findings indication and tracking
- Proper order entry
- LungRads classification and follow up recommendations
- Incidental Findings
International Collaboration in Research Using Healthcare Big Data and Development of Medical Informatics
Presenters: Dr. Wenzhao Shi, PhD, President and CEO, Digital China Health; Dr. Mengchun Gong, MD, SVP and CMIO, Digital China Health; Dr. Hua Xu, PhD, Robert H. Graham Professor, UTHealth School of Biomedical Informatics.
Meaningful use of healthcare Big Data relies heavily on the development and implementation of medical informatics. With the substantial expansion in healthcare Big Data application in China, medical informatics has been developing rapidly over the last few years. During this roundtable session, we will share our experience in establishing nationwide Big Data platforms for cancer and rare diseases. We will discuss the challenges and opportunities in the application of healthcare Big Data, as well as perspectives in terms of promoting the development of medical informatics in China. We are interested in hearing your insights on building up more productive collaboration between U.S. and China to facilitate the application of healthcare Big Data.
Target Audience: Clinical Informaticists, Medical Educators, Data Analysts, Clinicians, Researchers
To request an invitation for one or more roundtables, complete the form below. There is no additional fee to attend a roundtable, however you must complete the form to be considered. By completing the form, you understand that the sponsoring organization of your requested roundtable(s) will receive your personal information and may contact you. Only registered Annual Symposium attendees may participate in roundtables.